<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01122693</url>
  </required_header>
  <id_info>
    <org_study_id>eZono</org_study_id>
    <nct_id>NCT01122693</nct_id>
  </id_info>
  <brief_title>Comparison Between Two Ultrasound Technologies for Ultrasound-guided Catheter Placement in Regional Anesthesia</brief_title>
  <acronym>eZono</acronym>
  <official_title>A Prospective, Randomized Comparison Between Two Ultrasound Technologies for Ultrasound-guided Catheter Placement in Regional Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of ultrasound imaging techniques in regional anaesthesia is rapidly becoming an area&#xD;
      of increasing interest. It represents one of the largest changes that the field of regional&#xD;
      anaesthesia has seen. For the first time, the operator is able to view an image of the target&#xD;
      nerve directly, guide the needle under real-time observation, navigate away from sensitive&#xD;
      anatomy, and monitor the spread of local anaesthetic (LA).The key to successful regional&#xD;
      anaesthesia is deposition of LA accurately around the nerve structures.&#xD;
&#xD;
      In the past, electrical stimulation which relied on surface landmark identification, was used&#xD;
      for this. However, landmark techniques have limitations; variations in anatomy and nerve&#xD;
      physiology , as well as equipment accuracy have had an effect on success rates and&#xD;
      complications.&#xD;
&#xD;
      However, alongside the enthusiasm of ultrasound guidance in regional anaesthesia, there&#xD;
      should be a degree of informed scepticism. The widespread use of the various techniques of&#xD;
      ultrasound-guided regional blocks without adequate training raises the danger of malpractice&#xD;
      and subsequent impaired outcome.&#xD;
&#xD;
      Adequate education in the use of regional block techniques under ultrasound guidance is&#xD;
      essential. Recent technical developments have achieved higher ultrasound frequencies and&#xD;
      better image resolution, as well as better post-processing and user-friendliness.&#xD;
&#xD;
      The purpose of this study is to determine whether new technical features such as reference&#xD;
      images, higher ultrasound frequencies, better image resolution and smaller size and weight of&#xD;
      the ultrasound probes may improve outcome (clinical benefits) and may show an increased&#xD;
      efficacy and safety. And if the new technology of ultrasound images improves the training&#xD;
      quality of trainees and novices in the art of ultrasound-guided blocks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in time to perform the catheter placement in regional anesthesia</measure>
    <time_frame>first three days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in performance: Incidence of complications</measure>
    <time_frame>first three days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of success rate regarding correct catheter placement</measure>
    <time_frame>first three days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>standard 2D ultrasound images</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>high-quality 2D ultrasound images</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>nerve stimulation techniques</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>eZono - high-quality 2D ultrasound images</intervention_name>
    <description>higher ultrasound frequencies, better image resolution, better post-processing and user-friendliness.</description>
    <arm_group_label>high-quality 2D ultrasound images</arm_group_label>
    <arm_group_label>nerve stimulation techniques</arm_group_label>
    <arm_group_label>standard 2D ultrasound images</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard 2D ultrasound images</intervention_name>
    <description>current standard in two-dimensional (2D) ultrasound images</description>
    <arm_group_label>high-quality 2D ultrasound images</arm_group_label>
    <arm_group_label>nerve stimulation techniques</arm_group_label>
    <arm_group_label>standard 2D ultrasound images</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at the age of 18 and above who need a regional anesthesia catheter for&#xD;
             postoperative pain management after elective orthopedic surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in another trial according to the German Drug Law 30 days to and during&#xD;
             the study&#xD;
&#xD;
          -  Lacking willingness to save and hand out data within the study&#xD;
&#xD;
          -  Accommodation in an institution due to an official or judicial order&#xD;
&#xD;
          -  (Unclear) history of alcohol or substances disabuse&#xD;
&#xD;
          -  Absent knowledge of German language&#xD;
&#xD;
          -  Analphabetism&#xD;
&#xD;
          -  Allergy to local anesthesia or other ingredients of the intravenous solutions&#xD;
&#xD;
          -  For women: Pregnancy or positive pregnancy test within the preoperative screening&#xD;
&#xD;
          -  Operation due to case of emergency, polytrauma or pathologic fracture&#xD;
&#xD;
          -  American Society of Anaesthesiologists (ASA) classification greater than III&#xD;
&#xD;
          -  Peripheral or central edema&#xD;
&#xD;
          -  AIDS (according to the CDC-classification of HIV-infection: category C)&#xD;
&#xD;
          -  Immunosuppression therapy&#xD;
&#xD;
          -  History of bleeding tendency (e.g. von-Willebrand-disease, thrombocytopenia)&#xD;
&#xD;
          -  Derailed metabolic disorder (e.g. Diabetes mellitus (Glucose &gt; 300 mg/dl) during the&#xD;
             preoperative screening)&#xD;
&#xD;
          -  Known history of electrolyte disturbance (e.g. Hyperkalemia &gt; 5.8 mmol/l,&#xD;
             Hypernatraemia &gt; 155 mmol/l)&#xD;
&#xD;
          -  Known history of acid-base-dysbalances&#xD;
&#xD;
          -  History of intracranial hemorrhage within one year of participation in the study&#xD;
&#xD;
          -  Neurological or psychiatric disease with limited contractual capability&#xD;
&#xD;
          -  CHF (congestive heart failure) according to (New York Heart Association)&#xD;
             classification - NYHA class IV&#xD;
&#xD;
          -  Liver disease (CHILD B or C cirrhosis, end-stage liver disease (MELD-score greater&#xD;
             than 10)&#xD;
&#xD;
          -  Renal insufficiency (serum creatinine greater than 2.0 mg/dl or greater than 150&#xD;
             µmol/l or dependency of haemodialysis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin, Klinik für Anästhesiologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology and Operative Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>May 10, 2010</study_first_submitted>
  <study_first_submitted_qc>May 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2010</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Univ. Prof. Dr. med. Claudia Spies, Department of Anesthesiology and Operative Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum</investigator_title>
  </responsible_party>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Pain Medicine</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Nerve Blocks</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

